InsiderTrades

Form 4 for CRL Charles River Laboratories

Accepted 2025-05-16 00:00:00 ET · period of report 2025-05-15 · accession 0001127602-25-014711 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-05-16 2025-05-15 CRL MASSARO GEORGE Dir S - Sale $137.57 -140 5,575 -2% -$19.3K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-15 S D 35 $136.32 5,680 D — — (F1) This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
2 Common Common Stock 2025-05-15 S D 81 $137.68 5,599 D — — (F2) This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
3 Common Common Stock 2025-05-15 S D 24 $139.05 5,575 D — — (F3) This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.